GGrantIndex
← Leaderboards

Stella M Papa

Emory University

$8,841,731
Attributed
$11,608,659
Total exposure
13
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,608,659 · 13

By mechanism

R01$9,720,533 · 3
R21$983,525 · 2
R56$602,955 · 1
P51$301,646 · 7

Top collaborators

Most similar at Emory University

Same institution · by research overlap

Others in their field

Top investigators on “Neurons

Research focus

NeuronsMotorParkinson DiseaseLevodopaCorpus Striatum StructureParkinsonian DisordersPrimatesResponseBehaviorRattusChronicAnimal ModelCellsDopamineDyskinetic SyndromeBehavioralBrainPlayPhysiologicalBasal GangliaMediatingAreaViral VectorFunctional Disorder

Grant awards (32)

Gene therapy targeting striatal dysfunction for Parkinson’s disease$496,466
R01 · FY2025 · NS · contact PI
Gene therapy targeting striatal dysfunction for Parkinson’s disease$535,690
R01 · FY2024 · NS · contact PI
Gene therapy targeting striatal dysfunction for Parkinson’s disease$561,514
R01 · FY2023 · NS · contact PI
Regulation of Motor Function in Parkinson's Disease$646,042
R01 · FY2022 · NS · contact PI
Gene therapy targeting striatal dysfunction for Parkinson’s disease$559,773
R01 · FY2022 · NS · contact PI
Regulation of Motor Function in Parkinson's Disease$640,628
R01 · FY2021 · NS · contact PI
Dopamine signal transduction in striatal neurons in Parkinson’s disease$500,500
R21 · FY2021 · NS · contact PI
Regulation of Motor Function in Parkinson's Disease$638,182
R01 · FY2020 · NS · contact PI
Regulation of Motor Function in Parkinson's Disease$635,472
R01 · FY2019 · NS · contact PI
A novel gene therapy for motor symptoms of Parkinson's disease$483,025
R21 · FY2019 · NS · contact PI
Regulation of Motor Function in Parkinson's Disease$602,955
R56 · FY2018 · NS · contact PI
Manipulating Gene Expression in the Dyskinesias of Parkinson's Disease$47,979
R01 · FY2016 · NS · contact PI
Manipulating Gene Expression in the Dyskinesias of Parkinson's Disease$441,026
R01 · FY2015 · NS · contact PI
Manipulating Gene Expression in the Dyskinesias of Parkinson's Disease$443,793
R01 · FY2014 · NS · contact PI
Manipulating Gene Expression in the Dyskinesias of Parkinson's Disease$462,020
R01 · FY2013 · NS · contact PI
Regulation of Motor Function in Parkinson's Disease$339,680
R01 · FY2013 · NS · contact PI
Manipulating Gene Expression in the Dyskinesias of Parkinson's Disease$470,609
R01 · FY2012 · NS · contact PI
Regulation of Motor Function in Parkinson's Disease$345,920
R01 · FY2012 · NS · contact PI
Manipulating Gene Expression in the Dyskinesias of Parkinson's Disease$505,150
R01 · FY2011 · NS · contact PI
Regulation of Motor Function in Parkinson's Disease$327,680
R01 · FY2011 · NS · contact PI
MOTOR EFFECTS OF PDE10A INHIBITORS IN PRIMATES$41,159
P51 · FY2011 · RR · contact PI
REGULATION OF MOTOR FUNCTION IN PARKINSON'S DISEASE$41,159
P51 · FY2011 · RR · contact PI
NMDA RECEPTOR AS THERAPEUTIC TARGET FOR PARKINSON?S DISEASE$32,906
P51 · FY2011 · RR · contact PI
MOTOR EFFECTS DERMAL FIBROBLAST GRAFTS IN GLOBUS PALLIDUS- PARKINSONIAN PRIMATES$32,906
P51 · FY2011 · RR · contact PI
REGULATION OF MOTOR FUNCTION IN PARKINSON'S DISEASE$54,827
P51 · FY2010 · RR · contact PI
MOTOR EFFECTS OF PDE10A INHIBITORS IN PRIMATES$54,827
P51 · FY2010 · RR · contact PI
NMDA RECEPTOR AS THERAPEUTIC TARGET FOR PARKINSON?S DISEASE$43,862
P51 · FY2010 · RR · contact PI
Regulation of Motor Function in Parkinson's Disease$293,838
R01 · FY2008 · NS · contact PI
Regulation of Motor Function in Parkinson's Disease$294,170
R01 · FY2007 · NS · contact PI
Regulation of Motor Function in Parkinson's Disease$337,739
R01 · FY2006 · NS · contact PI
Regulation of Motor Function in Parkinson's Disease$350,863
R01 · FY2005 · NS
Regulation of Motor Function in Parkinson's Disease$346,299
R01 · FY2004 · NS